Wells Fargo Reiterates a Buy Rating on Maravai LifeSciences Holdings (MRVI)

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) is one of the best biotech penny stocks to buy right now. Wells Fargo analyst Brandon Couillard maintained a Buy rating on Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) on June 25, setting a price target of $4.00.

Is Maravai LifeSciences Holdings, Inc. (MRVI) the Top Stock to Buy According to 12 West Capital Management?

A researcher in a laboratory coat working with laboratory equipment for nucleic acids.

The analyst based the rating on Maravai LifeSciences Holdings, Inc.’s (NASDAQ:MRVI) recent leadership changes, stating that Raj Asarpota’s appointment as the CFO is a strategic move primarily because of his prowess in financial leadership and prior collaborations with the new CEO, Bernd Brust.

Couillard expects this transition to align with Maravai LifeSciences Holdings, Inc.’s (NASDAQ:MRVI) focus on strategic growth and financial discipline.

He added that Asarpota’s history of successful divestitures and acquisitions is expected to bring considerable operational efficiencies and value creation to Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI), supporting the optimistic outlook for the company.

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) supports the development of drug therapies, novel vaccines, and diagnostics to enable research on human diseases. The company’s operations are divided into the following segments: Nucleic Acid Production and Biologics Safety Testing.

While we acknowledge the potential of MRVI to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than MRVI and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.